Molecular mechanisms of amphetamine actions in Caenorhabditis elegans.
Amphetamine (AMPH) poses a serious hazard to public health. Defining the molecular targets of AMPH is essential to developing treatments for psychostimulant abuse. AMPH elicits its behavioral effects primarily by increasing extracellular dopamine (DA) levels through the reversal of the DA transporter (DAT) cycle and, as a consequence, altering DA signaling. In Caenorhabditis elegans, an excess of synaptic DA results in a loss of motility in water, termed swimming-induced paralysis (SWIP). Here we demonstrate that AMPH produces SWIP in a time- and dose-dependent manner in wild-type (wt) animals but has a reduced ability to generate SWIP in DAT knock out worms (dat-1). To determine whether D1-like and/or D2-like receptors are involved in AMPH-induced SWIP, we performed experiments in DOP-1 and DOP-4, and DOP-2, and DOP-3 receptor knockout animals, respectively. AMPH administration resulted in a reduced ability to induce SWIP in animals lacking DOP-3, DOP-4, and DOP-2 receptors. In contrast, in worms lacking DOP-1 receptors, AMPH-induced SWIP occurred at wt levels. Using microamperometry on C. elegans DA neurons, we determined that in contrast to wt cells, AMPH failed to promote DA efflux in dat-1 DA neurons. These data suggest that DA efflux is critical to sustaining SWIP behavior by signaling through DOP-3, DOP-4, and DOP-2. In a double mutant lacking both DAT-1 and DOP-1 expression, we found no ability of AMPH to induce SWIP or DA efflux. This result supports the paradigm that DA efflux through C. elegans DAT is required for AMPH-induced behaviors and does not require DOP-1 signaling.
Carvelli
Lucia
L
Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Matthies
Dawn S
DS
Galli
Aurelio
A
D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D030801:Animals, Genetically Modified; D001522:Behavior, Animal; D017173:Caenorhabditis elegans / Q000187:drug effects* / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism
D000662:Amphetamines; D050483:Dopamine Plasma Membrane Transport Proteins; D004298:Dopamine
Genetics. 1992 Jul;131(3):609-24
1321065
Brain Res. 1991 Jun 21;552(1):141-52
1833032
Nature. 1995 May 4;375(6526):73-8
7723846
Nature. 1996 Feb 15;379(6566):606-12
8628395
J Neurosci. 1992 Jul;12(7):2439-50
1319476
J Neurosci. 2004 Feb 4;24(5):1217-25
14762140
Parkinsonism Relat Disord. 2001 Jul;7(3):177-183
11331184
Neurosci Lett. 1996 Aug 30;215(1):53-6
8880752
J Neurochem. 1995 Feb;64(2):689-99
7830062
Genes Brain Behav. 2004 Oct;3(5):266-72
15344920
Drug Alcohol Depend. 1995 May;38(2):95-137
7671769
Neuron. 2000 Jun;26(3):619-31
10896158
J Neurosci. 1999 Nov 15;19(22):9831-40
10559392
J Biol Chem. 2003 Apr 4;278(14):12070-7
12556446
J Neurosci. 2000 Oct 1;20(19):7297-306
11007887
Science. 1988 Nov 4;242(4879):715-23
2903550
J Neurosci. 1993 Dec;13(12):5407-17
8254383
Neuron. 1995 Apr;14(4):803-12
7718242
Neurosci Biobehav Rev. 2000 Jan;24(1):125-32
10654668
J Neurochem. 2005 Aug;94(4):1146-57
16001968
J Neurosci. 1998 Mar 15;18(6):1979-86
9482784
Brain Res. 2003 Dec 24;994(2):203-15
14642646
Genetics. 1974 May;77(1):71-94
4366476
Annu Rev Pharmacol Toxicol. 2003;43:521-44
12415122
J Neurosci. 2007 Dec 19;27(51):14216-27
18094261
Neuron. 1995 Jan;14(1):79-89
7826644
J Comp Neurol. 1975 Sep 15;163(2):215-26
240872
Nat Neurosci. 2004 Oct;7(10):1096-103
15378064
Neurosci Lett. 2002 Feb 8;319(1):13-6
11814642
Biochemistry. 1992 Jul 28;31(29):6710-8
1322169
J Neurosci. 2001 Apr 15;21(8):2851-60
11306637
Prog Neurobiol. 2005 Apr;75(6):406-33
15955613
Neuron. 1990 Dec;5(6):797-808
2268433
J Neurosci. 1999 Jan 1;19(1):72-84
9870940
J Pharmacol Exp Ther. 1992 May;261(2):811-8
1349649
J Neurochem. 1993 Feb;60(2):527-35
8419534
Dev Neurosci. 1998;20(1):1-18
9600386
J Neurochem. 2003 Aug;86(4):869-78
12887685
Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16046-51
15520385
EMBO J. 2004 Jan 28;23(2):473-82
14739932
Physiol Rev. 1998 Jan;78(1):189-225
9457173
J Biol Chem. 1994 Jun 24;269(25):17215-20
8006030
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9333-8
16754872
J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):482-97
9276849
Cell Motil Cytoskeleton. 1991;20(1):69-78
1756579